IL-8–binding evasin (designated as EVA) and IL-6–binding affibody (designated as ZIL) were used to achieve cytokine removal, while EpCAM-binding affitin (designated as AFFI) and HER2-binding affibody (designated as ZHER) served for tumor antigen targeting. Here, CXCL8 is linked to neoplasm.